187 related articles for article (PubMed ID: 25519733)
21. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
[TBL] [Abstract][Full Text] [Related]
22. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C
Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322
[TBL] [Abstract][Full Text] [Related]
23. Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.
Li W; Sullivan MN; Zhang S; Worker CJ; Xiong Z; Speth RC; Feng Y
Hypertension; 2015 Feb; 65(2):352-61. PubMed ID: 25421983
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice.
Xia H; Feng Y; Obr TD; Hickman PJ; Lazartigues E
Hypertension; 2009 Feb; 53(2):210-6. PubMed ID: 19124678
[TBL] [Abstract][Full Text] [Related]
25. Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension.
Pitra S; Worker CJ; Feng Y; Stern JE
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H496-H504. PubMed ID: 31274353
[TBL] [Abstract][Full Text] [Related]
26. Lesion of the OVLT markedly attenuates chronic DOCA-salt hypertension in rats.
Collister JP; Nahey DB; Hartson R; Wiedmeyer CE; Banek CT; Osborn JW
Am J Physiol Regul Integr Comp Physiol; 2018 Sep; 315(3):R568-R575. PubMed ID: 29897819
[TBL] [Abstract][Full Text] [Related]
27. Endoplasmic reticulum stress in the brain subfornical organ contributes to sex differences in angiotensin-dependent hypertension in rats.
Dai SY; Fan J; Shen Y; He JJ; Peng W
Acta Physiol (Oxf); 2016 May; 217(1):33-44. PubMed ID: 26639993
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.
Zheng H; Liu X; Patel KP
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2402-12. PubMed ID: 21963832
[TBL] [Abstract][Full Text] [Related]
29. ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons.
Mukerjee S; Gao H; Xu J; Sato R; Zsombok A; Lazartigues E
Hypertension; 2019 Nov; 74(5):1181-1191. PubMed ID: 31564162
[TBL] [Abstract][Full Text] [Related]
30. Role of the median preoptic nucleus in the development of chronic deoxycorticosterone acetate (DOCA)-salt hypertension.
Collister JP; Fritcher N; Nahey D
Physiol Rep; 2024 May; 12(10):e16046. PubMed ID: 38749925
[TBL] [Abstract][Full Text] [Related]
31. Hypertension-induced cardiac impairment is reversed by the inhibition of endoplasmic reticulum stress.
Bal NB; Han S; Kiremitci S; Sadi G; Uludag O; Demirel-Yilmaz E
J Pharm Pharmacol; 2019 Dec; 71(12):1809-1821. PubMed ID: 31579948
[TBL] [Abstract][Full Text] [Related]
32. α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.
de Queiroz TM; Xia H; Filipeanu CM; Braga VA; Lazartigues E
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H926-34. PubMed ID: 26254330
[TBL] [Abstract][Full Text] [Related]
33. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
[TBL] [Abstract][Full Text] [Related]
34. Clinical Relevance and Role of Neuronal AT
Xu J; Sriramula S; Xia H; Moreno-Walton L; Culicchia F; Domenig O; Poglitsch M; Lazartigues E
Circ Res; 2017 Jun; 121(1):43-55. PubMed ID: 28512108
[TBL] [Abstract][Full Text] [Related]
35. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
[TBL] [Abstract][Full Text] [Related]
36. COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
Wang F; Sun Y; Luo R; Lu X; Yang B; Yang T
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F647-F653. PubMed ID: 32799674
[TBL] [Abstract][Full Text] [Related]
37. Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats.
Dai SY; Zhang YP; Peng W; Shen Y; He JJ
Oxid Med Cell Longev; 2016; 2016():3981790. PubMed ID: 26783414
[TBL] [Abstract][Full Text] [Related]
38. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
Feng Y; Hans C; McIlwain E; Varner KJ; Lazartigues E
PLoS One; 2012; 7(11):e48910. PubMed ID: 23155428
[TBL] [Abstract][Full Text] [Related]
40. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
